Killing of stationary staphylococcus aureus within microaggregates and macrophages by free sitafloxacin and sugar, or as carrier-free nanodrug
Colloids and Surfaces B: Biointerfaces · 2026-08 · 264 · 115648
DOI: 10.1016/j.colsurfb.2026.115648 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026-08. Verfasst von Elian M A Kuhn und 9 weiteren Autor:innen. Beteiligte Einrichtung: AO Research Institute Davos, Davos 7270, Switzerland; University of Basel, Basel 4056, Switzerland. Electronic address: elian.kuhn@aofoundation.org. Hauptthemen laut MEDLINE: Fluoroquinolones, Staphylococcus aureus, Anti-Bacterial Agents, Macrophages. Die Arbeit nennt 85 Literaturangaben. Gefördert von: Beijing University of Chemical Technology, AO Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Staphylococcus aureus infections often develop biofilms, abscesses, and intracellular reservoirs, which reduce antibiotic effectiveness. This reduced efficacy is partly due to bacterial metabolic inactivity. However, sugars can reactivate bacteria and restore their susceptibility. This study aims to identify effective combination of sitafloxacin and sugars and develop a carrier-free nanodrug delivery system to enhance treatment against metabolically inactive S. aureus. Sitafloxacin demonstrates the highest activity against stationary-phase USA300 S. aureus, achieving a ∼3 log10 bacterial reduction, which is more than tenfold enhanced when combined with glucose, fructose, or mannose. The antibacterial effects were confirmed in biofilm and abscess in vitro models, with sugars potentiating sitafloxacin in abscesses. Nanodrugs were synthesized by covalently linking sitafloxacin to sugars via Schiff-base bonds, allowing self-assembly into stable nanoparticles (∼100 nm). Antibiotic release reaches ∼35-40% over three days at physiological pH, indicating high stability. These nanodrugs reduce stationary and growing bacteria and in vitro abscesses by ∼2 log10 and biofilm bacteria by ∼4 log10, needing further refinement to achieve enhanced activity compared to free sitafloxacin. They accumulate in macrophages, reducing intracellular bacteria by 2 log10 without any cytotoxic effect. This novel nanosystem co-delivers antibiotic and sugar without inert carriers, demonstrating antimicrobial activity, biocompatibility, and delayed release, offering potential for targeting persistent bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AO Research Institute Davos, Davos 7270, Switzerland; University of Basel, Basel 4056, Switzerland. Electronic address: elian.kuhn@aofoundation.org.
- State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, China.
- AO Research Institute Davos, Davos 7270, Switzerland.
- Empa, The Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Biointerfaces, St. Gallen 9014, Switzerland.
- State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, China. Electronic address: wangxing@mail.buct.edu.cn.
- AO Research Institute Davos, Davos 7270, Switzerland; Center for Musculoskeletal Infections (ZMSI), University Hospital Basel, Basel 4056, Switzerland. Electronic address: fintan.moriarty@aofoundation.org.
Förderung
- Beijing University of Chemical Technology
- AO Foundation
- National Natural Science Foundation of China
Zitieren
APA
Kuhn, E. M. A., Chen, X., Chittò, M., Kiener, L. S., Li, G., Fu, Y., Siverino, C., Ren, Q., Wang, X., & Moriarty, T. F. (2026). Killing of stationary staphylococcus aureus within microaggregates and macrophages by free sitafloxacin and sugar, or as carrier-free nanodrug. Colloids and Surfaces B: Biointerfaces, 264, 115648. https://doi.org/10.1016/j.colsurfb.2026.115648
Vancouver
Kuhn EMA, Chen X, Chittò M, Kiener LS, Li G, Fu Y, et al. Killing of stationary staphylococcus aureus within microaggregates and macrophages by free sitafloxacin and sugar, or as carrier-free nanodrug. Colloids and Surfaces B: Biointerfaces. 2026;264:115648. doi:10.1016/j.colsurfb.2026.115648
BibTeX
@article{Kuhn2026,
author = {Kuhn, Elian M A and Chen, Xiyue and Chittò, Marco and Kiener, Livia S and Li, Guofeng and Fu, Yanan and Siverino, Claudia and Ren, Qun and Wang, Xing and Moriarty, T Fintan},
title = {Killing of stationary staphylococcus aureus within microaggregates and macrophages by free sitafloxacin and sugar, or as carrier-free nanodrug},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2026},
volume = {264},
pages = {115648},
doi = {10.1016/j.colsurfb.2026.115648}
}
EUVIMED